|By PR Newswire||
|January 31, 2014 12:26 PM EST||
DUBLIN, Ireland, January 31, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/sbps4g/pancreatic) has announced the addition of the "Pancreatic Cancer: Disease and Pipeline Analysis" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
This report provides insight into a market with few effective therapies.
ISR's latest report profiles the pancreatic cancer market because it is one in which few effective therapies are currently available and has a healthy clinical development pipeline, explained Andrew Schafer, President of ISR. The market data in this report is valuable for pharmaceutical and biopharmaceutical executives looking to optimize and benchmark their clinical development programs and better guide their commercial strategies by understanding the current and future competitive landscape.
The report provides a thorough overview of the disease, provides incidence figures for all major and emerging markets, profiles the clinical development status of over 60 potential new therapies, and discusses market specific drug approval dynamics, such as localized trial and recruitment environments, regulatory environments, competitive product landscape, and pricing and reimbursement environments.
Pancreatic cancer affects a relatively small number of people around the world, which in most markets classify it as an orphan' or rare disease, Schafer explained. This classification means favorable market conditions for pharmaceutical and biopharmaceutical sponsors willing to invest in new therapies in the form of tax breaks and market exclusivity upon regulatory approval.
The report is based on data compiled by ISR analysts in the first quarter of 2013.
Key Topics Covered:
Chapter 1. Pancreatic Cancer Overview
Chapter 2. Commercial Rationale
Chapter 3. Environmental Analysis
Chapter 4. Clinical Development Pipeline
Chapter 5. Clinical Trial Environment
For more information visit http://www.researchandmarkets.com/research/sbps4g/pancreatic
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Oct. 21, 2016 12:15 PM EDT Reads: 858
Oct. 21, 2016 12:00 PM EDT Reads: 668
Oct. 21, 2016 12:00 PM EDT Reads: 8,034
Oct. 21, 2016 11:00 AM EDT Reads: 908
Oct. 21, 2016 10:50 AM EDT Reads: 173
Oct. 21, 2016 10:45 AM EDT Reads: 1,633
Oct. 21, 2016 10:30 AM EDT Reads: 1,219
Oct. 21, 2016 10:30 AM EDT Reads: 527
Oct. 21, 2016 10:15 AM EDT Reads: 1,369
Oct. 21, 2016 09:30 AM EDT Reads: 1,124
Oct. 21, 2016 09:30 AM EDT Reads: 428
Oct. 21, 2016 09:15 AM EDT Reads: 246
Oct. 21, 2016 08:45 AM EDT Reads: 11,118
Oct. 21, 2016 08:45 AM EDT Reads: 1,366
Apache Hadoop is a key technology for gaining business insights from your Big Data, but the penetration into enterprises is shockingly low. In fact, Apache Hadoop and Big Data proponents recognize that this technology has not yet achieved its game-changing business potential. In his session at 19th Cloud Expo, John Mertic, director of program management for ODPi at The Linux Foundation, will explain why this is, how we can work together as an open data community to increase adoption, and the i...
Oct. 21, 2016 08:15 AM EDT Reads: 1,835